Approaches to Increase Equitable Access to and Delivery of Quality of Care with Bispecific Antibodies for Patients with Multiple Myeloma
Key Information
Direct Link to Opportunity
https://cdn.pfizer.com/pfizercom/2023-03/2023%20QI%20MM%20RFP%20-%20FINAL.pdf?ZuHhBN2g944f0BqqVmXZ5sn07XXLewpc=Application Deadline
Fund Type
Grant
Funding Agency
Pfizer
Agency Type
Non-Federal
Internal or External
External
Status of Applicants
See Opportunity Website
Discipline(s)
See Opportunity Website
Contact
See Opportunity Website